Literature DB >> 12483304

Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia.

Akihiko Mabuchi1, Noriyo Manabe, Nobuhiko Haga, Hiroshi Kitoh, Toshiyuki Ikeda, Hiroyuki Kawaji, Kazuya Tamai, Junichiro Hamada, Shigeru Nakamura, Nicola Brunetti-Pierri, Mamori Kimizuka, Yoshio Takatori, Kozo Nakamura, Gen Nishimura, Hirofumi Ohashi, Shiro Ikegawa.   

Abstract

Mutations in the gene encoding cartilage oligomeric matrix protein ( COMP) cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). More than 40 mutations have been identified; however, genotype-phenotype relationships are not well delineated. Further, mutations other than in-frame insertion/deletions and substitutions have not been found, and currently known mutations are clustered within relatively small regions. Here we report the identification of nine novel and three recurrent COMP mutations in PSACH and MED patients. These include two novel types of mutations; the first, a gross deletion spanning an exon-intron junction, causes an exon deletion. The second, a frameshift mutation that results in a truncation of the C-terminal domain, is the first known truncating mutation in the COMP gene. The remaining mutations, other than a novel exon 18 mutation, affected highly conserved aspartate or cysteine residues in the calmodulin-like repeat (CLR) region. Genotype-phenotype analysis revealed a correlation between the position and type of mutations and the severity of short stature. Mutations in the seventh CLR produced more severe short stature compared with mutations elsewhere in the CLRs ( P=0.0003) and elsewhere in the COMP gene ( P=0.0007). Patients carrying mutations within the five-aspartates repeat (aa 469-473) in the seventh CLR were extremely short (below -6 SD). Patients with deletion mutations were significantly shorter than those with substitution mutations ( P=0.0024). These findings expand the mutation spectrum of the COMP gene and highlight genotype-phenotype relationships, facilitating improved genetic diagnosis and analysis of COMP function in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483304     DOI: 10.1007/s00439-002-0845-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

Review 1.  Cartilage oligomeric matrix protein: COMPopathies and beyond.

Authors:  Karen L Posey; Francoise Coustry; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-03-09       Impact factor: 11.583

Review 2.  Genetic analysis of skeletal dysplasia: recent advances and perspectives in the post-genome-sequence era.

Authors:  Shiro Ikegawa
Journal:  J Hum Genet       Date:  2006-05-03       Impact factor: 3.172

Review 3.  COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia.

Authors:  Jason Kennedy; Gail Jackson; Simon Ramsden; Jacky Taylor; William Newman; Michael J Wright; Dian Donnai; Rob Elles; Michael D Briggs
Journal:  Eur J Hum Genet       Date:  2005-05       Impact factor: 4.246

4.  Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.

Authors:  Katarzyna A Piróg; Michael D Briggs
Journal:  J Biomed Biotechnol       Date:  2010-05-24

5.  Identification of cartilage oligomeric matrix protein (COMP) gene mutations in patients with pseudoachondroplasia and multiple epiphyseal dysplasia.

Authors:  Hae-Ryong Song; Kwang-Soo Lee; Qi-Wei Li; Soo Kyung Koo; Sung-Chul Jung
Journal:  J Hum Genet       Date:  2003-04-24       Impact factor: 3.172

6.  Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats.

Authors:  Marc Kvansakul; Josephine C Adams; Erhard Hohenester
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

7.  Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP).

Authors:  Luitgard Spitznagel; D Patric Nitsche; Mats Paulsson; Patrik Maurer; Frank Zaucke
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

8.  Zirconium oxide regulates RNA interfering of osteoblast-like cells.

Authors:  Annalisa Palmieri; Furio Pezzetti; Giorgio Brunelli; Ilaria Zollino; Lorenzo Lo Muzio; Marcella Martinelli; Luca Scapoli; Marzia Arlotti; Elena Masiero; Francesco Carinci
Journal:  J Mater Sci Mater Med       Date:  2008-02-06       Impact factor: 3.896

9.  Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin.

Authors:  Matthew J Rock; Paul Holden; William A Horton; Daniel H Cohn
Journal:  Mol Cell Biochem       Date:  2009-12-24       Impact factor: 3.396

10.  A novel COMP mutation in a pseudoachondroplasia family of Chinese origin.

Authors:  Li Dai; Liang Xie; Yanping Wang; Meng Mao; Nana Li; Jun Zhu; Christopher Kim; Yawei Zhang
Journal:  BMC Med Genet       Date:  2011-05-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.